Human Thrombomodulin enzyme-linked immunoassay kit
| Specification | 96 Test |
|---|---|
| Sensitivity | 3.73 pg/ml (50 μl);4.40 pg/ml (10 μl); |
| Standard Curve Range | 156.25 ~10000 pg/ml |
| Standard Curve Gradient | 7 Points |
| Number of Incubations | 2 |
| Detectable sample | Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc. |
| Sample Volume | 50 μl/10 μl |
| Type | Fully Ready-to-Use |
| Operation Duration | 120min |
| pg/ml | O.D. | Average | Corrected | |
|---|---|---|---|---|
| 0.00 | 0.0511 | 0.0490 | 0.0501 | |
| 156.25 | 0.1620 | 0.1604 | 0.1612 | 0.1112 |
| 312.50 | 0.2721 | 0.2656 | 0.2689 | 0.2188 |
| 625.00 | 0.4935 | 0.4966 | 0.4951 | 0.4450 |
| 1250.00 | 0.9292 | 0.9211 | 0.9252 | 0.8751 |
| 2500.00 | 1.7800 | 1.8000 | 1.7900 | 1.7400 |
| 5000.00 | 3.1980 | 3.0140 | 3.1060 | 3.0560 |
| 10000.00 | 4.1872 | 4.2956 | 4.2414 | 4.1914 |
Precision
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample Number | S1 | S2 | S3 | S1 | S2 | S3 |
| 22 | 22 | 22 | 6 | 6 | 6 | |
| Average(pg/ml) | 175.0 | 901.0 | 2768.8 | 192.8 | 960.4 | 3060.5 |
| Standard Deviation | 7.4 | 35.0 | 166.9 | 12.4 | 48.9 | 93.9 |
| Coefficient of Variation(%) | 4.2 | 3.9 | 6.0 | 6.4 | 5.1 | 3.1 |
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human Thrombomodulin into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 98% to 112% with an overall mean recovery of 105%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | 5246.47-10627.71 | 100 | 8020.10 |
Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human Thrombomodulin in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.
Product Data Sheet
Background: Thrombomodulin
Thrombomodulin (TM), also known as CD141 and BDCA3, is a transmembrane expressed on vascular endothelial cells (EC), arterial smooth muscle cells, monocytes, and macrophages. It binds Thrombin and enhances the Thrombin-mediated activation of the anti-coagulant Protein C and the anti-fibrinolytic TAFI/Carboxypeptidase B2. Thrombomodulin also inhibits the ability of Thrombin to activate several pro-coagulant proteins (e.g. Fibrinogen, Factor V, Factor XIII, PAR-1). Thrombomodulin exerts multiple anti-inflammatory effects and reduces the severity of disease involving chronic inflammation. In cancer, Thrombomodulin suppresses tumor angiogenesis, growth, and epithelial-mesenchymal transition. Soluble fragments of Thrombomodulin are elevated in the serum, urine, and synovial fluid during coagulation disorders, inflammation, and organ failure.
